Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TP53 |
Variant | F341V |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | TP53 F341V lies within the tetramerization domain of the Tp53 protein (PMID: 20978130). F341V results in the inability to form Tp53 tetramers and decreased Tp53 transcriptional activity in yeast assays (PMID: 16007150), but has not been characterized in human cells and therefore, its effect on Tp53 function is unknown. |
Associated Drug Resistance | |
Category Variants Paths |
TP53 mutant TP53 exon10 TP53 F341V |
Transcript | NM_000546.6 |
gDNA | chr17:g.7670688A>C |
cDNA | c.1021T>G |
Protein | p.F341V |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001407262.1 | chr17:g.7670688A>C | c.1021T>G | p.F341V | RefSeq | GRCh38/hg38 |
NM_000546.5 | chr17:g.7670688A>C | c.1021T>G | p.F341V | RefSeq | GRCh38/hg38 |
NM_001407264.1 | chr17:g.7670688A>C | c.1021T>G | p.F341V | RefSeq | GRCh38/hg38 |
NM_001126112.3 | chr17:g.7670688A>C | c.1021T>G | p.F341V | RefSeq | GRCh38/hg38 |
NM_001126113.3 | chr17:g.7673239A>C | c.1021T>G | p.F341V | RefSeq | GRCh38/hg38 |
NM_001407266.1 | chr17:g.7670688A>C | c.1021T>G | p.F341V | RefSeq | GRCh38/hg38 |
NM_001126112.2 | chr17:g.7670688A>C | c.1021T>G | p.F341V | RefSeq | GRCh38/hg38 |
NM_001126112 | chr17:g.7670688A>C | c.1021T>G | p.F341V | RefSeq | GRCh38/hg38 |
NM_000546 | chr17:g.7670688A>C | c.1021T>G | p.F341V | RefSeq | GRCh38/hg38 |
NM_000546.6 | chr17:g.7670688A>C | c.1021T>G | p.F341V | RefSeq | GRCh38/hg38 |
NM_001126113.2 | chr17:g.7673239A>C | c.1021T>G | p.F341V | RefSeq | GRCh38/hg38 |
NM_001126113 | chr17:g.7673239A>C | c.1021T>G | p.F341V | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|